Deferoxamine Mesylate and Insulin glulisine Subcutaneous
Determining the interaction of Deferoxamine Mesylate and Insulin glulisine Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: deferoxamine
Brand name: Desferal
Synonyms: Deferoxamine
Generic Name: insulin glulisine
Brand name: Apidra, Apidra OptiClik Cartridge, Apidra SoloStar Pen
Synonyms: Insulin glulisine, Insulin Glulisine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Deferoxamine Mesylate-Insulin human inhaled Inhalation
- Deferoxamine Mesylate-Insulin human regular Injection
- Deferoxamine Mesylate-Insulin inhalation
- Deferoxamine Mesylate-Insulin isophane
- Deferoxamine Mesylate-Insulin isophane and insulin regular
- Deferoxamine Mesylate-Insulin lispro
- Insulin glulisine Subcutaneous-Defibrotide
- Insulin glulisine Subcutaneous-Defibrotide Intravenous
- Insulin glulisine Subcutaneous-Defibrotide Sodium
- Insulin glulisine Subcutaneous-Definity
- Insulin glulisine Subcutaneous-Defitelio
- Insulin glulisine Subcutaneous-Deflazacort